News

April 20, 2026

NOF Exhibiting Latest LNP Technology at AACR Annual Meeting 2026

Tokyo, Japan — NOF CORPORATION is pleased to announce its participation in the ongoing American Association for Cancer Research Annual Meeting 2026 (AACR 2026) which is taking place at the San Diego Convention Center, San Diego, CA, USA from April 17 to 22.

AACR 2026 highlights the latest breakthroughs in cancer research and clinical trials.

As a part of the event, NOF CORPORATION showcases its products and services for Drug Delivery System at Booth #1721 through April 22.

For further information regarding the conference or other inquiries, please refer to the contact form.
* Please select “Life Science” for the Business division field.


Key Products and Services

1.  LNP Platform

  • Proprietary Ionizable Lipid Library
  • Screening & Formulation Optimization Services
  • Targeting LNP Development Service
  • GMP-grade Lipid Supply

2. SUNBRIGHT® / PUREBRIGHT® Series PEG Derivatives

  • Activated PEGs for the modification of therapeutic proteins/peptides
  • PEG-Lipids for LNPs
  • Releasable and degradable PEGs for PEGylation to Cytokines
  • Monodisperse PEG linkers for ADCs/PDCs.

3. Customized Synthesis Services

  • Expert CDMO services for lipids and PEGs, including:
    • PEG lipids & PEG Phospholipids
    • Cationic Lipids & Proprietary Ionizable Lipids
    • Synthetic Phospholipids
    • Activated PEGs
    • Monodisperse PEG linkers
  • Extensive support in:
    • Process Development
    • Scale-up production
    • GMP manufacturing

See also:


[View in PDF]